fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Savings

Savings Calculator

Updated on November 26, 2020 , 601 views

What is wealth accumulation calculator?

To secure a more financially stable future, one needs to have financial discipline in his younger formative years. Wealth accumulation is one of the most satisfactory things that can be achieved with the money which a person has currently. Suppose, you are 30 now and you have 30 more years to invest towards your retirement. To accumulate wealth for retirement, you need to decide for how long you want to receive the annuities from the plan. Say, you want to receive an annuity of Rs. 50,000 for a period of 30 years – up to age 90 – (50,000*30), you need to calculate how much you must invest as a corpus at the rate of the current interest. This is where a wealth accumulation calculator can help you

Savings Calculator

Principal:
Tenure:
Months
Rate of Interest (ROI):
%

Investment Amount:₹400,000

Interest Earned:₹115,720.87

Maturity Amount: ₹515,720.87

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Why should you have a financial plan in place

Other than a comprehensive Financial plan, there is no shortcut to secure a comfortable financial future. After working all these years, you deserve that comfort and peace of mind. You can spend your golden years travelling and catch up with your peers or enjoy a laid back life with your loved ones. financial planning is all about chasing your dreams (short or long term) without having to think about the money. Financial planning will prepare you for any emergency (that money can solve) and give you peace that even if something unfortunate happens to you, your family will not suffer.

Analyze your current situation: Do you have your insurances (medical, vehicle or Life Insurance) in place? Are you able to put aside a certain amount regularly after expenses? Do you have a plan B for emergency situations? What about outstanding loans and dues, if any? Answers to these can help you analyze this

Existing Debts: Nothing gives the financially conscientious a bigger nightmare than debts. With credit card companies, banks and NBFCs issuing unsecured loans to people from all income class, people rely a lot on instant loans to take care of their immediate needs. This has to change. Start by paying off a little more than required and close the debts at the earliest

Allocate Assets Wisely: When you choose assets to invest in, understand the purpose of the particular product. For instance, if you balance your equity investments with Debt fund or a safer financial tool like FD, it can spread the risks. Balancing is a key step to wealth accumulation

To build wealth or save tax: You must focus on a diversified investment portfolio that can do both – then only you can accumulate wealth. Do you know which tax slab you belong to and what are the legal options (including 80c deductions) you have to save tax? There are excellent opportunities like ELSS which will help you to build wealth and save tax at the same time

Top Funds for 2020

*Best funds based on 1 year performance.

1. UTI Healthcare Fund

(Erstwhile UTI Pharma & Healthcare Fund)

The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors.

UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a CAGR/Annualized return of 14.3% since its launch.  Ranked 40 in Sectoral category.  Return for 2019 was 1.2% , 2018 was -7.5% and 2017 was 6.2% .

Below is the key information for UTI Healthcare Fund

UTI Healthcare Fund
Growth
Launch Date 28 Jun 99
NAV (27 Nov 20) ₹133.512 ↑ 1.62   (1.23 %)
Net Assets (Cr) ₹586 on 31 Oct 20
Category Equity - Sectoral
AMC UTI Asset Management Company Ltd
Rating
Risk High
Expense Ratio 2.59
Sharpe Ratio 1.49
Information Ratio 0.56
Alpha Ratio 8.16
Min Investment 5,000
Min SIP Investment 500
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
31 Oct 15₹10,000
31 Oct 16₹9,297
31 Oct 17₹8,425
31 Oct 18₹8,458
31 Oct 19₹8,101
31 Oct 20₹12,515

UTI Healthcare Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹367,070.
Net Profit of ₹67,070
Invest Now

Returns for UTI Healthcare Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 27 Nov 20

DurationReturns
1 Month 3.3%
3 Month 6.4%
6 Month 32.6%
1 Year 57%
3 Year 15.5%
5 Year 7.6%
10 Year
15 Year
Since launch 14.3%
Historical performance (Yearly) on absolute basis
YearReturns
2019 1.2%
2018 -7.5%
2017 6.2%
2016 -9.7%
2015 12.4%
2014 43.7%
2013 23.3%
2012 24.8%
2011 -9.6%
2010 37.4%
Fund Manager information for UTI Healthcare Fund
NameSinceTenure
V Srivatsa3 Mar 173.67 Yr.

Data below for UTI Healthcare Fund as on 31 Oct 20

Equity Sector Allocation
SectorValue
Health Care93.17%
Basic Materials2.61%
Asset Allocation
Asset ClassValue
Cash4.22%
Equity95.78%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | 500124
10%₹61 Cr124,140
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA
10%₹58 Cr1,239,120
Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | 500087
8%₹47 Cr627,094
↑ 67,819
Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB
7%₹44 Cr139,142
↓ -9,278
Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Oct 13 | AUROPHARMA
7%₹39 Cr505,945
↑ 196,705
Cadila Healthcare Ltd (Healthcare)
Equity, Since 31 Jan 03 | 532321
6%₹37 Cr877,425
↑ 29,214
Ipca Laboratories Ltd (Healthcare)
Equity, Since 31 Jan 14 | 524494
6%₹35 Cr150,995
↓ -13,432
Eris Lifesciences Ltd Registered Shs (Healthcare)
Equity, Since 31 Mar 19 | 540596
4%₹23 Cr456,812
↑ 10,000
Biocon Ltd (Healthcare)
Equity, Since 31 Oct 18 | 532523
4%₹22 Cr533,700
Narayana Hrudayalaya Ltd (Healthcare)
Equity, Since 31 Jan 20 | NH
4%₹21 Cr614,870

2. Nippon India Pharma Fund

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

Nippon India Pharma Fund is a Equity - Sectoral fund was launched on 5 Jun 04. It is a fund with High risk and has given a CAGR/Annualized return of 21.2% since its launch.  Ranked 35 in Sectoral category.  Return for 2019 was 1.7% , 2018 was 3.6% and 2017 was 7.6% .

Below is the key information for Nippon India Pharma Fund

Nippon India Pharma Fund
Growth
Launch Date 5 Jun 04
NAV (27 Nov 20) ₹237.658 ↑ 2.41   (1.02 %)
Net Assets (Cr) ₹3,900 on 31 Oct 20
Category Equity - Sectoral
AMC Nippon Life Asset Management Ltd.
Rating
Risk High
Expense Ratio 2.33
Sharpe Ratio 1.39
Information Ratio 1.25
Alpha Ratio 5.26
Min Investment 5,000
Min SIP Investment 100
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Growth of 10,000 investment over the years.

DateValue
31 Oct 15₹10,000
31 Oct 16₹9,393
31 Oct 17₹8,479
31 Oct 18₹9,907
31 Oct 19₹9,440
31 Oct 20₹14,106

Nippon India Pharma Fund SIP Returns

   
My Monthly Investment:
Investment Tenure:
Years
Expected Annual Returns:
%
Total investment amount is ₹300,000
expected amount after 5 Years is ₹395,578.
Net Profit of ₹95,578
Invest Now

Returns for Nippon India Pharma Fund

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 27 Nov 20

DurationReturns
1 Month 4.9%
3 Month 7%
6 Month 31.1%
1 Year 56%
3 Year 20.2%
5 Year 10.3%
10 Year
15 Year
Since launch 21.2%
Historical performance (Yearly) on absolute basis
YearReturns
2019 1.7%
2018 3.6%
2017 7.6%
2016 -10.6%
2015 19.4%
2014 49.5%
2013 20.9%
2012 34.8%
2011 -11%
2010 31.9%
Fund Manager information for Nippon India Pharma Fund
NameSinceTenure
Sailesh Raj Bhan1 Apr 0515.6 Yr.
Kinjal Desai25 May 182.44 Yr.

Data below for Nippon India Pharma Fund as on 31 Oct 20

Equity Sector Allocation
SectorValue
Health Care96.52%
Asset Allocation
Asset ClassValue
Cash3.48%
Equity96.52%
Top Securities Holdings / Portfolio
NameHoldingValueQuantity
Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB
10%₹377 Cr1,200,075
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 09 | SUNPHARMA
10%₹373 Cr8,000,976
↑ 400,000
Aurobindo Pharma Ltd (Healthcare)
Equity, Since 31 Dec 15 | AUROPHARMA
9%₹364 Cr4,710,000
↓ -200,000
Cipla Ltd (Healthcare)
Equity, Since 31 May 08 | 500087
9%₹355 Cr4,700,000
Lupin Ltd (Healthcare)
Equity, Since 31 Aug 08 | 500257
9%₹346 Cr3,800,025
↓ -200,000
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 30 Jun 11 | 500124
8%₹293 Cr600,000
↓ -125,000
Thyrocare Technologies Ltd (Healthcare)
Equity, Since 31 May 16 | THYROCARE
7%₹267 Cr2,323,279
↓ -531,640
Cadila Healthcare Ltd (Healthcare)
Equity, Since 31 Jan 18 | 532321
5%₹198 Cr4,748,982
↑ 750,000
Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Aug 18 | 532843
5%₹181 Cr14,403,541
Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Sep 20 | APOLLOHOSP
4%₹172 Cr811,506
↑ 519,003

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data. Please verify with scheme information document before making any investment.
How helpful was this page ?
POST A COMMENT